Your browser doesn't support javascript.
loading
Analysis of angiogenesis biomarkers for ramucirumab efficacy in patients with metastatic colorectal cancer from RAISE, a global, randomized, double-blind, phase III study.
Tabernero, J; Hozak, R R; Yoshino, T; Cohn, A L; Obermannova, R; Bodoky, G; Garcia-Carbonero, R; Ciuleanu, T-E; Portnoy, D C; Prausová, J; Muro, K; Siegel, R W; Konrad, R J; Ouyang, H; Melemed, S A; Ferry, D; Nasroulah, F; Van Cutsem, E.
Afiliación
  • Tabernero J; Medical Oncology, Vall d'Hebron University Hospital and Institute of Oncology (VHIO), Barcelona, Spain; CIBERONC, Universitat Autònoma de Barcelona, Barcelona, Spain. Electronic address: jtabernero@vhio.net.
  • Hozak RR; Oncology, Eli Lilly and Company, Indianapolis, USA.
  • Yoshino T; Division of Gastrointestinal Oncology/Digestive Endoscopy, National Cancer Center Hospital East, Chiba, Japan.
  • Cohn AL; Medical Oncology, Rocky Mountain Cancer Center/US Oncology, Denver, USA.
  • Obermannova R; Department of Comprehensive Cancer Care, Masaryk Memorial Cancer Institute, Brno, Czech Republic.
  • Bodoky G; Oncology, Szent László Hospital, Budapest, Hungary.
  • Garcia-Carbonero R; Medical Oncology Department, Hospital Universitario 12 de Octubre, CNIO; CIBERONC, Universidad Complutense, Madrid, Spain.
  • Ciuleanu TE; Medical Oncology, Prof. Dr. I. Chiricuta Institute of Oncology, Cluj-Napoca, Romania.
  • Portnoy DC; Oncology, West Clinic, Memphis, USA.
  • Prausová J; Department of Oncology and Radiotherapy, University Hospital Motol, Prague, Czech Republic.
  • Muro K; Department of Clinical Oncology, Aichi Cancer Center Hospital, Nagoya, Japan.
  • Siegel RW; Laboratory for Experimental Medicine, Eli Lilly and Company, Indianapolis, USA.
  • Konrad RJ; Laboratory for Experimental Medicine, Eli Lilly and Company, Indianapolis, USA.
  • Ouyang H; Oncology, Eli Lilly and Company, Indianapolis, USA.
  • Melemed SA; Oncology, Eli Lilly and Company, Indianapolis, USA.
  • Ferry D; Oncology, Eli Lilly and Company, Indianapolis, USA.
  • Nasroulah F; Oncology, Eli Lilly and Company, Argentina.
  • Van Cutsem E; Digestive Oncology, University Hospital Gasthuisberg, Leuven, Belgium; KU Leuven, Leuven, Belgium.
Ann Oncol ; 29(3): 602-609, 2018 03 01.
Article en En | MEDLINE | ID: mdl-29228087
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Neoplasias Colorrectales / Biomarcadores de Tumor / Factor D de Crecimiento Endotelial Vascular / Antineoplásicos Inmunológicos / Anticuerpos Monoclonales Tipo de estudio: Clinical_trials / Prognostic_studies Límite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Ann Oncol Asunto de la revista: NEOPLASIAS Año: 2018 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Neoplasias Colorrectales / Biomarcadores de Tumor / Factor D de Crecimiento Endotelial Vascular / Antineoplásicos Inmunológicos / Anticuerpos Monoclonales Tipo de estudio: Clinical_trials / Prognostic_studies Límite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Ann Oncol Asunto de la revista: NEOPLASIAS Año: 2018 Tipo del documento: Article